PsychoGenics Inc.

About PsychoGenics Inc.

PsychoGenics is a preclinical Contract Research Organization (CRO) specializing in central nervous system (CNS) and orphan disorders. Their mission is to provide validated disease models and comprehensive preclinical capabilities to help companies discover breakthroughs for severely disabling CNS and orphan disorders, while reducing attrition rates in clinical development. They offer customized solutions and cutting-edge translational research to support clients in quantifying treatment efficacy before clinical stages.

Products & Services

Preclinical CNS Services:Includes behavioral and in vivo testing, drug abuse liability, EEG studies, electrophysiology, ex vivo sample biomarker analysis, histology & immunohistochemistry, microdialysis, pharmacokinetic & pharmacodynamic services, and receptor occupancy.

Therapeutic Areas:Covers mental illnesses, neurodegenerative disorders, neurodevelopmental disorders, neuromuscular disorders, pain disorders, rare CNS disorders, sleep & seizure disorders, and traumatic brain & spinal cord injuries.

In Vivo AI Platforms:Includes proprietary technologies like eCube™, NeuroCube®, PhenoCube®, and SmartCube® for neuropsychiatric drug discovery.

Emerging Therapies:Focuses on cell and gene therapies, microbiome research, and psychedelics.

Specialties

Central Nervous System (CNS) Disorders Orphan Disorders Preclinical Drug Discovery Behavioral Testing Electrophysiology Translational EEG Quantitative Histology Molecular Biology Microdialysis AI-Enabled Drug Discovery Platforms

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: SBIR Grant (Fast Track Small Business Innovation Research) T: - FT: SBIR Grant (Fast Track Small Business Innovation Research)	A: 3000000 MR: - FA: $3 million FAN: 3000000	D: 2024-08-28 FD: 2024-08-28	1 investors

SBIR Grant (Fast Track Small Business Innovation Research) Latest

2024-08-28

$3.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

E

Emer Leahy

President and CEO

D

Dani Brunner

Chief Innovation Officer, Chief Technology Officer

T

Taleen Hanania

Chief Commercial Officer

S

Sylvie Ramboz

Chief Operations Officer

A

Afshin Ghavami

Chief Research Officer

S

Stephen Morairty

VP, Translational Neuroscience

View 5 more team members with Pro

Unlock Full Team Directory

Recent News